PYXIS ONCOLOGY INC. - COMMON STOCK

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201

19 Dec 2024 15:08:10 By Nasdaq GlobeNewswire

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

20 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024

12 Nov 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201

11 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

29 Aug 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024

14 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference

29 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 Jun 2024 15:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

10 Jun 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

30 May 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

14 May 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference

09 May 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

27 Mar 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

21 Mar 2024 06:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

13 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

07 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

05 Mar 2024 15:45:00 By Nasdaq GlobeNewswire

Pyxis Oncology Announces $50 Million Private Placement

27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Dec 2023 15:30:00 By Nasdaq GlobeNewswire